从事消化道疾病的内镜下诊治及基础研究工作20余年，主持并完成国家和省市级课题8项，其中科委课题5项，市级课题2项，国家级课题1项，以第一作者或通信作者发表论文二十余篇，其中SCI论文十余篇，单篇最高影响因子23.655，参与编写专著2部。
日本昭和大学横滨市北部病院进修消化道早癌的内镜下诊治，美国芝加哥大学医学院消化病研究所访问学者。2020年作为虹口区高层次人才引进至上海市第四人民医院担任学科带头人。
与中国科学院上海硅酸盐研究所合作，作为通讯作者于JACS，Nano-Micro Letters等杂志发表纳米催化医学相关论文。
Dr Zhou engages in clinical and basic research in Endoscopic diagnosis and treatment of digestive diseases for more than 20 years. Presided over and completed 6 national, bureau-level research projects. As the first author or corresponding author, she published more than 20 papers, including more than 10 SCI papers，the highest impact factor for a single article is 23.655, and participated in 2 medical books. She pursued endoscopic diagnosis and treatment of early gastrointestinal cancers at Showa University Northern Yokohama Hospital , and worked at the Section of Gastroenterology, Department of Medicine, University of Chicago as a visiting scholar. In 2020, as a high-level talent in Hongkou District, introduced to the Fourth People’s Hospital of Shanghai as a discipline leader.
The group cooperated with Shanghai Institute of Ceramics, Chinese Academy of Sciences and published papers as corresponding author related to nanocatalytic medicine in JACS, Nano-Micro Letters and other journals.
代表性论文：
(1) Wu W, Pu Y, Gao S, Shen Y, Zhou M, Yao H, Shi J. Bacterial Metabolism-Initiated Nanocatalytic Tumor Immunotherapy. Nanomicro Lett. 2022 Nov 11;14(1):220. （IF 23.655）
(2) Wu W, Pu Y, Zhou B, Shen Y, Gao S, Zhou M, Shi J. Photoactivatable Immunostimulatory Nanomedicine for Immunometabolic Cancer Therapy. J Am Chem Soc. 2022 Oct 19;144(41):19038-19050. （IF：16.383 ）
(3) Zhou, Min; Qu, Chun-Ying; Ding, Wen-Jin; Cai, Xiao-Lei; Shen, Yu-Jie; Chen, Ying-Wei; Xu,Lei-Ming ; Preliminary study on the inhibitory effect of tumor suppressor gene KPC1 on the proliferation in gastric carcinoma cell, Annals of Translational Medicine, 2020, 8(6): 0-343. （IF:3.932）
(4) Zheng, Nan-Nan; Zhou, Min; Sun, Fang; Huai, Man-Xiu; Zhang, Yi; Qu, Chun-Ying; Shen, Feng; Xu, Lei-Ming; Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression, World Journal of Gastroenterology, 2020, 26(26): 3737-3749.（IF:5.742）
(5) Shen, Yujie; Zhou, Min; Yan, Junkai; Gong, Zizhen; Xiao, Yongtao; Zhang, Cong; Du, Peng;Chen, Yingwei ; miR-200b inhibits TNF-alpha-induced IL-8 secretion and tight junction disruption of intestinal epithelial cells in vitro, American Journal of Physiology - Gastrointestinal and Liver Physiology, 2017, 312(2): G123-G132 .（IF:4.5）
(6) Zhou, Min; Ding, Wen-Jin; Chen, Ying-Wei; Shen, Feng; Zeng, Jun-Yi; Qu, Chun-Ying; Wei, Yun-Feng; Xu, Lei-Ming; Expression Changes of Long Noncoding RNA in the Process of Endothelial Cell Activation, Cellular Physiology and Biochemistry, 2017, 41(1): 115-123.（IF:5.5）
（7）Ding, Wen-Jin; Zhou, Min; Chen, Mei-Mei; Qu, Chun-Ying; HOXB8 promotes tumor metastasis and the epithelial-mesenchymal transition via ZEB2 targets in gastric cancer. Journal of Cancer Research and Clinical Oncology 2017, 143(3): 385-397. （IF:3.282）
